Leeds-based Surgical Innovations Group reports record £12.01m revenues in 2023, with UK sales growth of 8% and a promising order book.
Leeds-based Surgical Innovations Group reported record revenues of £12.01m for the year ending 31 December 2023, an increase of 6% from the previous year. Despite a pre-tax loss of £728,000 and adjusted EBITDA profit of £200,000, Chairman Jonathan Glenn stated the company is on a sustainable growth trajectory for 2024 and beyond, with an encouraging order book. UK sales growth was 8% year-on-year, representing 64% of total revenues.
April 18, 2024
3 Articles